Development of highly sensitive molecular diagnosis based on glyco-nanobiotechnology

Yasuo Suda

[P-767] Development of highly sensitive molecular diagnosis based on glyco-nanobiotechnology

^○Yasuo Suda^1,4, Masanori Baba¹, Yasuhisa Tajima², Ikkou Higashimoto³, Hirohito Tsubouchi³, Jun-ichiro Nishi¹, Toshiyuki Chosa⁴, Takashi Kajiya⁵ (1.Kagoshima University, 2.Hamamatsu Medical Center, 3.Kagoshima City Hospital, 4.SUDx-Biotec Corp., 5.Kirishima Medical Center, 6.Tenyoukai Central Hospital)

キーテクノロジー：糖鎖ナノバイオテクノロジー

検査診断、糖鎖ナノバイオテクノロジー、ウイルス、インフルエンザウイルス、新型コロナウイルス

ysuda@sudxbiotec.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 93rd Annual Meeting of JBS

[P-767] Development of highly sensitive molecular diagnosis based on glyco-nanobiotechnology

Password